Barclays’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,500
Closed -$802K 6374
2020
Q1
$802K Buy
16,500
+16,000
+3,200% +$942K ﹤0.01% 3180
2019
Q4
$32K Sell
500
-20,800
-98% -$1.23M ﹤0.01% 5873
2019
Q3
$1.08M Hold
21,300
﹤0.01% 3588
2019
Q2
$1.02M Buy
21,300
+20,500
+2,563% +$1.04M ﹤0.01% 3662
2019
Q1
$44K Sell
800
-5,600
-88% -$254K ﹤0.01% 5973
2018
Q4
$235K Sell
6,400
-5,100
-44% -$239K ﹤0.01% 4465
2018
Q3
$675K Sell
11,500
-6,200
-35% -$396K ﹤0.01% 4011
2018
Q2
$1.16M Sell
17,700
-1,000
-5% -$62.2K ﹤0.01% 3122
2018
Q1
$1.09M Buy
18,700
+1,900
+11% +$129K ﹤0.01% 3099
2017
Q4
$1.14M Sell
16,800
-9,600
-36% -$652K ﹤0.01% 2987
2017
Q3
$1.89M Sell
26,400
-5,400
-17% -$397K ﹤0.01% 2411
2017
Q2
$2.43M Buy
31,800
+15,600
+96% +$1.28M ﹤0.01% 2080
2017
Q1
$1.34M Sell
16,200
-172,900
-91% -$13.9M ﹤0.01% 2457
2016
Q4
$14.6M Sell
189,100
-13,600
-7% -$1.03M 0.02% 762
2016
Q3
$16.2M Buy
202,700
+193,400
+2,080% +$17.5M 0.02% 634
2016
Q2
$968K Buy
9,300
+2,800
+43% +$300K ﹤0.01% 2640
2016
Q1
$819K Buy
6,500
+100
+2% +$11.6K ﹤0.01% 2704
2015
Q4
$768K Buy
6,400
+5,000
+357% +$637K ﹤0.01% 2841
2015
Q3
$195K Hold
1,400
﹤0.01% 4157
2015
Q2
$186K Buy
1,400
+700
+100% +$95.9K ﹤0.01% 4195
2015
Q1
$98K Sell
700
-700
-50% -$94.5K ﹤0.01% 4867
2014
Q4
$183K Sell
1,400
-1,100
-44% -$138K ﹤0.01% 4723
2014
Q3
$290K Sell
2,500
-72,400
-97% -$8.55M ﹤0.01% 4421
2014
Q2
$8.84M Buy
74,900
+68,400
+1,052% +$7.83M 0.01% 1251
2014
Q1
$735K Buy
6,500
+2,800
+76% +$324K ﹤0.01% 3566
2013
Q4
$429K Buy
3,700
+2,100
+131% +$245K ﹤0.01% 4253
2013
Q3
$184K Sell
1,600
-3,700
-70% -$427K ﹤0.01% 5127
2013
Q2
$585K Buy
+5,300
New +$576K ﹤0.01% 4024

Other funds holding SRCL

Barclays's SRCL Position: Q4 2024 in Review

Barclays sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 1,595,177 shares — an estimated $97.3M sold.

Barclays first reported a position in SRCL in Q2 2013 and held it in 46 quarters. The position peaked at $97.3M in Q3 2024. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • Barclays reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • Barclays sold 1,595,177 Stericycle Inc shares in Q4 2024, an estimated $97.3M.
  • Barclays first reported a position in Stericycle Inc in Q2 2013 and held it in 46 quarters.
  • Barclays's Stericycle Inc position peaked at $97.3M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.